Erlocip 150 Tablets

Product Description

1. Technical Specifications

---

2. Product Description

Erlocip 150 Tablet contains Erlotinib, a tyrosine kinase inhibitor (TKI) that specifically targets the epidermal growth factor receptor (EGFR). Many cancers show abnormal EGFR signaling, which leads to uncontrolled growth. Erlocip works by blocking this pathway, thereby slowing or stopping cancer cell proliferation.

It is widely prescribed for non-small cell lung cancer (NSCLC) and advanced pancreatic cancer, either alone or in combination with chemotherapy.

---

3. Product Highlights

---

4. Therapeutic Uses

• Non-Small Cell Lung Cancer (NSCLC): First-line treatment in EGFR mutation-positive patients.

• Pancreatic Cancer: Used with gemcitabine in locally advanced/metastatic cases.

• Other EGFR-driven cancers: Sometimes prescribed off-label, based on oncologists recommendation.

---

5. Side Effects

Common:

• Rash, acne-like eruptions

• Diarrhea

• Nausea, vomiting

• Fatigue, weakness

• Loss of appetite

Serious / Severe:

• Interstitial lung disease (serious lung complications, rare but fatal)

• Liver toxicity (jaundice, dark urine, abnormal liver enzymes)

• Gastrointestinal perforation (very rare, life-threatening)

• Severe skin reactions (StevensJohnson syndrome, toxic epidermal necrolysis)

• Eye irritation, conjunctivitis, corneal ulceration

---

6. Precautions

• Smoking: Reduces Erlotinib effectiveness; patients should avoid smoking completely.

• Liver & Kidney Function: Regular monitoring; dosage adjustment may be required.

• Pregnancy & Lactation: Contraindicated may cause harm to fetus or infant.

• Drug Interactions:

  • Avoid CYP3A4 inducers/inhibitors (rifampicin, ketoconazole, clarithromycin).

  • Avoid proton pump inhibitors (omeprazole, pantoprazole) as they reduce absorption.

• Skin & Eye Care: Report persistent rash, eye pain, or vision problems immediately.

Pure Yeast-Based Formulation

Erlocip 150 Tablets are crafted using 100% yeast, making them a reliable option for those seeking pure and potent ingredients. The formulation is tailored to deliver the therapeutic benefits associated with yeast-derived compounds, ensuring safe and effective results for patients and healthcare providers alike.


Internationally Distributed and Trusted

As a leading exporter, supplier, trader, and wholesaler from India, Erlocip 150 Tablets reach markets worldwide. Our rigorous quality assurance standards and robust distribution networks help us deliver authentic products consistently to global clients, supporting various therapeutic needs effectively.